Michael Kiehl

7.5k total citations · 1 hit paper
87 papers, 3.6k citations indexed

About

Michael Kiehl is a scholar working on Hematology, Oncology and Epidemiology. According to data from OpenAlex, Michael Kiehl has authored 87 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Hematology, 32 papers in Oncology and 30 papers in Epidemiology. Recurrent topics in Michael Kiehl's work include Neutropenia and Cancer Infections (24 papers), Hematopoietic Stem Cell Transplantation (20 papers) and Antifungal resistance and susceptibility (12 papers). Michael Kiehl is often cited by papers focused on Neutropenia and Cancer Infections (24 papers), Hematopoietic Stem Cell Transplantation (20 papers) and Antifungal resistance and susceptibility (12 papers). Michael Kiehl collaborates with scholars based in Germany, United States and Austria. Michael Kiehl's co-authors include Rainer Schwerdtfeger, Herbert G. Sayer, Matthias Kochanek, Nicolaus Kröger, Dieter Buchheidt, Joachim Kienast, Gernot Beutel, Axel R. Zander, Frank Kroschinsky and Tatjana Zabelina and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Michael Kiehl

83 papers receiving 3.5k citations

Hit Papers

New drugs, new toxicities: severe side effects of modern ... 2017 2026 2020 2023 2017 100 200 300

Peers

Michael Kiehl
Michael Kiehl
Citations per year, relative to Michael Kiehl Michael Kiehl (= 1×) peers Lourdes Vázquez

Countries citing papers authored by Michael Kiehl

Since Specialization
Citations

This map shows the geographic impact of Michael Kiehl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kiehl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kiehl more than expected).

Fields of papers citing papers by Michael Kiehl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Kiehl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kiehl. The network helps show where Michael Kiehl may publish in the future.

Co-authorship network of co-authors of Michael Kiehl

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Kiehl. A scholar is included among the top collaborators of Michael Kiehl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Kiehl. Michael Kiehl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lueck, Catherina, Philipp Wohlfarth, Michael Kiehl, et al.. (2022). Impact of chronic graft-versus-host-disease on intensive care outcome in allogeneic hematopoietic stem cell recipients. Bone Marrow Transplantation. 58(3). 303–310. 3 indexed citations
2.
Al‐Sawaf, Othman, Sandra Robrecht, Jasmin Bahlo, et al.. (2020). Richter transformation in chronic lymphocytic leukemia (CLL)—a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials. Leukemia. 35(1). 169–176. 62 indexed citations
3.
Kochanek, Matthias, Alexander Shimabukuro‐Vornhagen, Gernot Beutel, et al.. (2019). Prävalenz von Krebspatienten auf deutschen Intensivstationen. Medizinische Klinik - Intensivmedizin und Notfallmedizin. 115(4). 312–319. 8 indexed citations
4.
Mika, Thomas, Alexander Baraniskin, Deepak Vangala, et al.. (2019). Allogeneic hematopoietic stem cell transplantation for primary central nervous system lymphoma. Haematologica. 105(4). e160–e163. 6 indexed citations
5.
6.
Bräuninger, Andreas, Wolfgang Blau, Alexander Brobeil, et al.. (2018). Targeted Next-Generation Sequencing Is a Sensitive Tool for Differential Diagnosis of Myelodysplastic Syndromes in Bone Marrow Trephines. Journal of Molecular Diagnostics. 20(3). 344–354. 6 indexed citations
7.
Ullmann, Andrew J., Martin Schmidt‐Hieber, Hartmut Bertz, et al.. (2016). Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016. Annals of Hematology. 95(9). 1435–1455. 133 indexed citations
8.
Schellongowski, Peter, et al.. (2016). Intensive care for cancer patients. memo - Magazine of European Medical Oncology. 9(1). 39–44. 11 indexed citations
9.
Penack, Olaf, Dieter Buchheidt, Maximilian Christopeit, et al.. (2014). Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO). Annals of Hematology. 93(7). 1083–1095. 62 indexed citations
10.
Hopfer, Olaf, et al.. (2013). Tumorinduzierte Hyperkalzämie. Der Internist. 54(9). 1043–1050. 1 indexed citations
11.
Reinwald, Mark, Michael Hummel, Birgit Spieß, et al.. (2012). Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies. Journal of Antimicrobial Chemotherapy. 67(9). 2260–2267. 80 indexed citations
12.
Rieger, C., Oliver A. Cornely, Torsten Hoppe‐Tichy, et al.. (2012). Treatment cost of invasive fungal disease (Ifd) in patients with acute myelogenous leukaemia (Aml) or myelodysplastic syndrome (Mds) in German hospitals. Mycoses. 55(6). 514–520. 20 indexed citations
14.
Penack, Olaf, T. Beinert, Dieter Buchheidt, et al.. (2006). Management of sepsis in neutropenia: guidelines of the infectious diseases working party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Annals of Hematology. 85(9). 639–639. 1 indexed citations
15.
Kröger, Nicolaus, Bronwen E. Shaw, Simona Iacobelli, et al.. (2005). Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR‐ligand mismatch after dose‐reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma. British Journal of Haematology. 129(5). 631–643. 82 indexed citations
16.
Bornhäuser, Martin, Nicolaus Kröger, Rainer Schwerdtfeger, et al.. (2005). Allogeneic haematopoietic cell transplantation for chronic myelogenous leukaemia in the era of imatinib: a retrospective multicentre study. European Journal Of Haematology. 76(1). 9–17. 29 indexed citations
17.
Ehninger, Gerhard, Rainer Schwerdtfeger, Harald Biersack, et al.. (2003). Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia. Annals of Hematology. 82(6). 336–342. 83 indexed citations
18.
Kiehl, Michael, et al.. (2002). Immunomodulation with immunoglobulins for autoimmune diseases and infections. Thieme eBooks. 1 indexed citations
19.
Basara, Nadežda, Igor‐Wolfgang Blau, Michael Kiehl, et al.. (1998). Chronic Eosinophilic Leukemia: Successful Treatment with an Unrelated Bone Marrow Transplantation. Leukemia & lymphoma. 32(1-2). 189–193. 21 indexed citations
20.
Kiehl, Michael, et al.. (1996). Volume-controlled versus biphasic positive airway pressure ventilation in leukopenic patients with severe respiratory failure. Critical Care Medicine. 24(5). 780–784. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026